TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs58896911
log Bayes Factor = 10.2837
Chromosome 7   position 28,639,955  (GRCh37) Explore rs58896911 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
I25 Chronic ischaemic heart disease
1.000 0.000 0.000
I25.8 Other forms of chronic ischaemic heart disease
1.000 0.000 0.000
I25.1 Atherosclerotic heart disease
1.000 0.000 0.000
I25.9 Chronic ischaemic heart disease, unspecified
0.998 0.002 0.000
I25.2 Old myocardial infarction
0.996 0.004 0.000
I20-I25 Ischaemic heart diseases
0.989 0.011 0.000
I20 Angina pectoris
0.987 0.013 0.000
I20.9 Angina pectoris, unspecified
0.977 0.023 0.000
I21 Acute myocardial infarction
0.935 0.065 0.000
I21.4 Acute subendocardial myocardial infarction
0.893 0.107 0.000
I21.1 Acute transmural myocardial infarction of inferior wall
0.884 0.116 0.000
I25.4 Coronary artery aneurysm
0.870 0.130 0.000
I20.1 Angina pectoris with documented spasm
0.850 0.150 0.000
I25.5 Ischaemic cardiomyopathy
0.827 0.173 0.000
I20.0 Unstable angina
0.807 0.193 0.000
I25.0 Atherosclerotic cardiovascular disease, so described
0.805 0.195 0.000
I20.8 Other forms of angina pectoris
0.794 0.206 0.000
I25.6 Silent myocardial ischaemia
0.717 0.283 0.000
I23 Certain current complications following acute myocardial infarction
0.710 0.290 0.000
I21.3 Acute transmural myocardial infarction of unspecified site
0.692 0.308 0.000
I21.X Presumed acute myicardial infaction (unconfirmed)
0.670 0.330 0.000
I21.0 Acute transmural myocardial infarction of anterior wall
0.659 0.341 0.000
I25.3 Aneurysm of heart
0.603 0.397 0.000
I22 Subsequent myocardial infarction
0.590 0.410 0.000
I23.8 Other current complications following acute myocardial infarction
0.510 0.490 0.000
I23.6 Thrombosis of atrium, auricular appendage and ventricle as current complications following acute myocardial infarction
0.509 0.491 0.000
I23.5 Rupture of papillary muscle as current complication following acute myocardial infarction
0.509 0.491 0.000
I23.4 Rupture of chordae tendineae as current complication following acute myocardial infarction
0.509 0.491 0.000
I23.3 Rupture of cardiac wall without haemopericardium as current complication following acute myocardial infarction
0.509 0.491 0.000
I23.2 Ventricular septal defect as current complication following acute myocardial infarction
0.509 0.491 0.000
I23.1 Atrial septal defect as current complication following acute myocardial infarction
0.509 0.491 0.000
I23.0 Haemopericardium as current complication following acute myocardial infarction
0.509 0.491 0.000
I21.2 Acute transmural myocardial infarction of other sites
0.505 0.495 0.000
I22.1 Subsequent myocardial infarction of inferior wall
0.453 0.547 0.000
I22.9 Subsequent myocardial infarction of unspecified site
0.420 0.580 0.000
I22.8 Subsequent myocardial infarction of other sites
0.361 0.639 0.000
I22.0 Subsequent myocardial infarction of anterior wall
0.339 0.661 0.000
I24 Other acute ischaemic heart diseases
0.305 0.695 0.001
I24.0 Coronary thrombosis not resulting in myocardial infarction
0.221 0.778 0.000
I24.1 Dressler's syndrome
0.219 0.781 0.001
C83.3 Large cell (diffuse)
0.172 0.828 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.145 0.855 0.000
I24.8 Other forms of acute ischaemic heart disease
0.133 0.866 0.000
C83.0 Small cell (diffuse)
0.126 0.874 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.110 0.890 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.110 0.890 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.110 0.890 0.000
I21.9 Acute myocardial infarction, unspecified
0.107 0.893 0.000
C83.7 Burkitt's tumour
0.104 0.896 0.000
C83.6 Undifferentiated (diffuse)
0.104 0.896 0.000
C83.5 Lymphoblastic (diffuse)
0.104 0.896 0.000
C83.4 Immunoblastic (diffuse)
0.104 0.896 0.000
C83.2 Mixed small and large cell (diffuse)
0.104 0.896 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.102 0.898 0.000
C85.1 B-cell lymphoma, unspecified
0.098 0.902 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.092 0.908 0.000
C92 Myeloid leukaemia
0.090 0.910 0.000
Z95.8 Presence of other cardiac and vascular implants and grafts
0.089 0.911 0.000
C83.1 Small cleaved cell (diffuse)
0.085 0.915 0.000
Z95 Presence of cardiac and vascular implants and grafts
0.084 0.916 0.000
C88 Malignant immunoproliferative diseases
0.082 0.918 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.082 0.918 0.000
C95 Leukaemia of unspecified cell type
0.082 0.918 0.000
C91 Lymphoid leukaemia
0.080 0.920 0.000
C92.1 Chronic myeloid leukaemia
0.080 0.920 0.000
Z95.4 Presence of other heart-valve replacement
0.079 0.921 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.079 0.921 0.000
C94 Other leukaemias of specified cell type
0.079 0.921 0.000
C93 Monocytic leukaemia
0.079 0.921 0.000
C86 Other specified types of T/NK-cell lymphoma
0.079 0.921 0.000
C90.2 Plasmacytoma, extramedullary
0.079 0.921 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.078 0.922 0.000
Z95.5 Presence of coronary angioplasty implant and graft
0.075 0.925 0.000
Z95.3 Presence of xenogenic heart valve
0.074 0.926 0.000
Z95.1 Presence of aortocoronary bypass graft
0.074 0.926 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.073 0.927 0.000
C85.0 Lymphosarcoma
0.073 0.927 0.000
C90.0 Multiple myeloma
0.067 0.932 0.000
C91.9 Lymphoid leukaemia, unspecified
0.067 0.933 0.000
C90.3 Solitary plasmacytoma
0.066 0.934 0.000
C90.1 Plasma cell leukaemia
0.066 0.934 0.000
C92.9 Myeloid leukaemia, unspecified
0.065 0.935 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.065 0.935 0.000
C92.7 Other myeloid leukaemia
0.065 0.935 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.065 0.935 0.000
C92.5 Acute myelomonocytic leukaemia
0.065 0.935 0.000
C92.4 Acute promyelocytic leukaemia
0.065 0.935 0.000
C92.3 Myeloid sarcoma
0.065 0.935 0.000
C92.2 Subacute myeloid leukaemia
0.065 0.935 0.000
C91.4 Hairy-cell leukaemia
0.064 0.936 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.063 0.937 0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified
0.063 0.937 0.000
C95.9 Leukaemia, unspecified
0.062 0.938 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.059 0.941 0.000
C88.7 Other malignant immunoproliferative diseases
0.059 0.941 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.059 0.941 0.000
C88.3 Immunoproliferative small intestinal disease
0.059 0.941 0.000
C88.2 Gamma heavy chain disease
0.059 0.941 0.000
C88.1 Alpha heavy chain disease
0.059 0.941 0.000
C95.7 Other leukaemia of unspecified cell type
0.059 0.941 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.059 0.941 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.059 0.941 0.000
C95.0 Acute leukaemia of unspecified cell type
0.059 0.941 0.000
C91.0 Acute lymphoblastic leukaemia
0.058 0.942 0.000
C84.4 Peripheral T-cell lymphoma
0.058 0.942 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.058 0.942 0.000
C91.7 Other lymphoid leukaemia
0.058 0.942 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.058 0.942 0.000
C91.5 Adult T-cell leukaemia
0.058 0.942 0.000
C91.3 Prolymphocytic leukaemia
0.058 0.942 0.000
C91.2 Subacute lymphocytic leukaemia
0.058 0.942 0.000
C92.0 Acute myeloid leukaemia
0.058 0.942 0.000
C81 Hodgkin's disease
0.057 0.943 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.057 0.943 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.057 0.943 0.000
C86.4 Blastic NK-cell lymphoma
0.057 0.943 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.057 0.943 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.057 0.943 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.057 0.943 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.057 0.943 0.000
C93.9 Monocytic leukaemia, unspecified
0.057 0.943 0.000
C93.7 Other monocytic leukaemia
0.057 0.943 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.057 0.943 0.000
C93.2 Subacute monocytic leukaemia
0.057 0.943 0.000
C93.1 Chronic monocytic leukaemia
0.057 0.943 0.000
C93.0 Acute monocytic leukaemia
0.057 0.943 0.000
C94.7 Other specified leukaemias
0.057 0.943 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.057 0.943 0.000
C94.5 Acute myelofibrosis
0.057 0.943 0.000
C94.4 Acute panmyelosis
0.057 0.943 0.000
C94.3 Mast cell leukaemia
0.057 0.943 0.000
C94.2 Acute megakaryoblastic leukaemia
0.057 0.943 0.000
C94.1 Chronic erythraemia
0.057 0.943 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.057 0.943 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.057 0.943 0.000
C96.8 Histiocytic sarcoma
0.057 0.943 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.057 0.943 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.057 0.943 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.057 0.943 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.057 0.943 0.000
C96.3 True histiocytic lymphoma
0.057 0.943 0.000
C96.2 Malignant mast cell tumour
0.057 0.943 0.000
C96.1 Malignant histiocytosis
0.057 0.943 0.000
C96.0 Letterer-Siwe disease
0.057 0.943 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.056 0.944 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.056 0.944 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.056 0.944 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.056 0.944 0.000
C84.3 Lymphoepithelioid lymphoma
0.056 0.944 0.000
C84.2 T-zone lymphoma
0.056 0.944 0.000
C84.1 Sezary's diease
0.056 0.944 0.000
C84.0 Mycosis fungoides
0.056 0.944 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.054 0.945 0.000
Z95.2 Presence of prosthetic heart valve
0.052 0.948 0.000
C84.5 Other and unspecified T-cell lymphomas
0.052 0.948 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.052 0.948 0.000
I24.9 Acute ischaemic heart disease, unspecified
0.050 0.948 0.002
G62.8 Other specified polyneuropathies
0.045 0.955 0.000
G62.9 Polyneuropathy, unspecified
0.045 0.955 0.000
G62 Other polyneuropathies
0.045 0.955 0.000
C81.7 Other Hodgkin's disease
0.041 0.959 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.041 0.959 0.000
C81.3 Lymphocytic depletion
0.041 0.959 0.000
C81.2 Mixed cellularity
0.041 0.959 0.000
C81.0 Lymphocytic predominance
0.041 0.959 0.000
C82.0 Small cleaved cell, follicular
0.040 0.960 0.000
C81.1 Nodular sclerosis
0.039 0.961 0.000
C82.6 Cutaneous follicle centre lymphoma
0.037 0.962 0.000
C82.5 Diffuse follicle centre lymphoma
0.037 0.962 0.000
C82.4 Follicular lymphoma grade IIIb
0.037 0.962 0.000
C82.3 Follicular lymphoma grade IIIa
0.037 0.962 0.000
C82.2 Large cell, follicular
0.037 0.962 0.000
G60-G64 Polyneuropathies and other disorders of the peripheral nervous system
0.035 0.965 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.034 0.966 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.033 0.966 0.000
G62.2 Polyneuropathy due to other toxic agents
0.032 0.968 0.000
G62.1 Alcoholic polyneuropathy
0.032 0.968 0.000
G61 Inflammatory polyneuropathy
0.031 0.969 0.000
C91.1 Chronic lymphocytic leukaemia
0.031 0.969 0.000
G62.0 Drug-induced polyneuropathy
0.030 0.969 0.000
E10 Insulin-dependent diabetes mellitus
0.030 0.970 0.000
E10.9 Without complications
0.030 0.970 0.000
E10.3 With ophthalmic complications
0.029 0.971 0.000
G63 Polyneuropathy in diseases classified elsewhere
0.029 0.971 0.000
G61.8 Other inflammatory polyneuropathies
0.029 0.971 0.000
Z95.0 Presence of cardiac pacemaker
0.029 0.971 0.000
E10.5 With peripheral circulatory complications
0.027 0.973 0.000
E10.2 With renal complications
0.027 0.973 0.000
E10.4 With neurological complications
0.026 0.974 0.000
G60 Hereditary and idiopathic neuropathy
0.025 0.974 0.000
G63.2 Diabetic polyneuropathy
0.025 0.975 0.000
G64 Other disorders of peripheral nervous system
0.025 0.975 0.000
E10.8 With unspecified complications
0.024 0.976 0.000
C81.9 Hodgkin's disease, unspecified
0.022 0.977 0.001
G61.9 Inflammatory polyneuropathy, unspecified
0.022 0.977 0.000
G61.1 Serum neuropathy
0.022 0.977 0.000
E10.7 With multiple complications
0.022 0.978 0.000
E10.6 With other specified complications
0.022 0.978 0.000
G61.0 Guillain-Barre syndrome
0.021 0.978 0.000
G63.8 Polyneuropathy in other diseases classified elsewhere
0.021 0.979 0.000
G63.6 Polyneuropathy in other musculoskeletal disorders
0.021 0.979 0.000
G63.5 Polyneuropathy in systemic connective tissue disorders
0.021 0.979 0.000
G63.4 Polyneuropathy in nutritional deficiency
0.021 0.979 0.000
G63.3 Polyneuropathy in other endocrine and metabolic diseases
0.021 0.979 0.000
G63.1 Polyneuropathy in neoplastic disease
0.021 0.979 0.000
G63.0 Polyneuropathy in infectious and parasitic diseases classified elsewhere
0.021 0.979 0.000
G60.0 Hereditary motor and sensory neuropathy
0.021 0.979 0.000
E10.0 With coma
0.020 0.980 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.020 0.980 0.000
G60.9 Hereditary and idiopathic neuropathy, unspecified
0.018 0.981 0.000
G60.3 Idiopathic progressive neuropathy
0.018 0.981 0.000
G60.2 Neuropathy in association with hereditary ataxia
0.018 0.981 0.000
G60.1 Refsum's disease
0.018 0.981 0.000
G60.8 Other hereditary and idiopathic neuropathies
0.016 0.984 0.000
E10.1 With ketoacidosis
0.014 0.986 0.000
Z30.2 Sterilisation
0.012 0.988 0.000
Z46.6 Fitting and adjustment of urinary device
0.010 0.990 0.000
Z30 Contraceptive management
0.008 0.992 0.000
C25.9 Pancreas, unspecified
0.000 0.992 0.008
Z30.3 Menstrual extraction
0.007 0.993 0.000
E10-E14 Diabetes mellitus
0.007 0.993 0.000
Z30.1 Insertion of (intra-uterine) contraceptive device
0.007 0.993 0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device
0.007 0.993 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.007 0.993 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.007 0.993 0.000
Y52 Agents primarily affecting the cardiovascular system
0.007 0.993 0.000
I12.0 Hypertensive renal disease with renal failure
0.007 0.993 0.000
Y42.7 Androgens and anabolic congeners
0.007 0.993 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.007 0.993 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.007 0.993 0.000
K85.9 Acute pancreatitis, unspecified
0.006 0.994 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.006 0.994 0.000
Z01.8 Other specified special examinations
0.006 0.994 0.000
Z30.9 Contraceptive management, unspecified
0.006 0.994 0.000
Z30.4 Surveillance of contraceptive drugs
0.006 0.994 0.000
V89 Motor- or nonmotor-vehicle accident, type of vehicle unspecified
0.006 0.994 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.006 0.994 0.000
C25.0 Head of pancreas
0.000 0.994 0.006
Chapter XX External causes of morbidity and mortality
0.006 0.994 0.000
C25 Malignant neoplasm of pancreas
0.000 0.994 0.006
V80-V89 Other land transport accidents
0.006 0.994 0.000
K14.8 Other diseases of tongue
0.000 0.994 0.006
V40-V49 Car occupant injured in transport accident
0.006 0.994 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.006 0.994 0.000
V89.2 Person injured in unspecified motor-vehicle accident, traffic
0.006 0.994 0.000
Y89.9 Sequelae of unspecified external cause
0.006 0.994 0.000
V49 Car occupant injured in other and unspecified transport accidents
0.006 0.994 0.000
E14 Unspecified diabetes mellitus
0.006 0.994 0.000
Y00-Y09 Assault
0.006 0.994 0.000
Y89 Sequelae of other external causes
0.006 0.994 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.006 0.994 0.000
V89.9 Person injured in unspecified vehicle accident
0.006 0.994 0.000
E12 Malnutrition-related diabetes mellitus
0.005 0.994 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.005 0.994 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.005 0.994 0.000
I12 Hypertensive renal disease
0.005 0.994 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.005 0.995 0.000
Chapter IX Diseases of the circulatory system
0.005 0.995 0.000
Y00 Assault by blunt object
0.005 0.995 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.005 0.995 0.000
K85.1 Biliary acute pancreatitis
0.005 0.995 0.000
Y00.9 Unspecified place
0.005 0.995 0.000
Z30.8 Other contraceptive management
0.005 0.995 0.000
M54.56 Low back pain (Lumbar region)
0.000 0.995 0.005
K85 Acute pancreatitis
0.005 0.995 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.005 0.995 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.005 0.995 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.005 0.995 0.000
Y52.7 Peripheral vasodilators
0.005 0.995 0.000
Y52.1 Calcium-channel blockers
0.005 0.995 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.005 0.995 0.000
Y59 Other and unspecified vaccines and biological substances
0.005 0.995 0.000
Y58 Bacterial vaccines
0.005 0.995 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.005 0.995 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.005 0.995 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.005 0.995 0.000
V49.9 Car occupant [any] injured in unspecified traffic accident
0.005 0.995 0.000
Y57 Other and unspecified drugs and medicaments
0.005 0.995 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.005 0.995 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.005 0.995 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.005 0.995 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.005 0.995 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.005 0.995 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.005 0.995 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.005 0.995 0.000
Y51.0 Anticholinesterase agents
0.005 0.995 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.005 0.995 0.000
V10-V19 Pedal cyclist injured in transport accident
0.005 0.995 0.000
Z30.0 General counselling and advice on contraception
0.005 0.995 0.000
Y85 Sequelae of transport accidents
0.005 0.995 0.000
W85-W99 Exposure to electric current, radiation and extreme ambient air temperature and pressure
0.005 0.995 0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes
0.005 0.995 0.000
V01-V09 Pedestrian injured in transport accident
0.005 0.995 0.000
V49.6 Unspecified car occupant injured in collision with other and unspecified motor vehicles in traffic accident
0.005 0.995 0.000
V20-V29 Motorcycle rider injured in transport accident
0.005 0.995 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.005 0.995 0.000
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident
0.005 0.995 0.000
C25.2 Tail of pancreas
0.000 0.995 0.005
X50-X57 Overexertion, travel and privation
0.005 0.995 0.000
E14.9 Without complications
0.005 0.995 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.005 0.995 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.005 0.995 0.000
Y49.5 Other antipsychotics and neuroleptics
0.005 0.995 0.000
V48 Car occupant injured in noncollision transport accident
0.005 0.995 0.000
W50-W64 Exposure to animate mechanical forces
0.005 0.995 0.000
V89.3 Person injured in unspecified nonmotor-vehicle accident, traffic
0.005 0.995 0.000
V89.1 Person injured in unspecified nonmotor-vehicle accident, nontraffic
0.005 0.995 0.000
V89.0 Person injured in unspecified motor-vehicle accident, nontraffic
0.005 0.995 0.000
Y42.9 Other and unspecified hormone antagonists
0.005 0.995 0.000
Y42.4 Oral contraceptives
0.005 0.995 0.000
Y42.2 Antithyroid drugs
0.005 0.995 0.000
Y42.1 Thyroid hormones and substitutes
0.005 0.995 0.000
Y54.8 Agents affecting uric acid metabolism
0.005 0.995 0.000
X58-X59 Accidental exposure to other and unspecified factors
0.005 0.995 0.000
K85.2 Alcohol-induced acute pancreatitis
0.005 0.995 0.000
V80 Animal-rider or occupant of animal-drawn vehicle injured in transport accident
0.005 0.995 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.005 0.995 0.000
I10-I15 Hypertensive diseases
0.005 0.995 0.000
Y57.5 X-ray contrast media
0.005 0.995 0.000
Y48 Anaesthetics and therapeutic gases
0.004 0.995 0.000
Y35-Y36 Legal intervention and operations of war
0.005 0.995 0.000
Y10-Y34 Event of undetermined intent
0.005 0.995 0.000
X85-X99 Assault
0.005 0.995 0.000
X30-X39 Exposure to forces of nature
0.005 0.995 0.000
X00-X09 Exposure to smoke, fire and flames
0.005 0.995 0.000
W75-W84 Other accidental threats to breathing
0.005 0.995 0.000
W65-W74 Accidental drowning and submersion
0.005 0.995 0.000
V98-V99 Other and unspecified transport accidents
0.005 0.995 0.000
V95-V97 Air and space transport accidents
0.005 0.995 0.000
V90-V94 Water transport accidents
0.005 0.995 0.000
V70-V79 Bus occupant injured in transport accident
0.005 0.995 0.000
V60-V69 Occupant of heavy transport vehicle injured in transport accident
0.005 0.995 0.000
V50-V59 Occupant of pick-up truck or van injured in transport accident
0.005 0.995 0.000
V30-V39 Occupant of three-wheeled motor vehicle injured in transport accident
0.005 0.995 0.000
V44 Car occupant injured in collision with heavy transport vehicle or bus
0.004 0.995 0.000
C25.8 Overlapping lesion of pancreas
0.000 0.995 0.004
C25.7 Other parts of pancreas
0.000 0.995 0.004
C25.4 Endocrine pancreas
0.000 0.995 0.004
C25.3 Pancreatic duct
0.000 0.995 0.004
C25.1 Body of pancreas
0.000 0.995 0.004
Y42.0 Glucocorticoids and synthetic analogs
0.005 0.995 0.000
V88 Nontraffic accident of specified type but victim's mode of transport unknown
0.004 0.995 0.000
V87 Traffic accident of specified type but victim's mode of transport unknown
0.004 0.995 0.000
V86 Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident
0.004 0.995 0.000
V85 Occupant of special construction vehicle injured in transport accident
0.004 0.995 0.000
V84 Occupant of special vehicle mainly used in agriculture injured in transport accident
0.004 0.995 0.000
V83 Occupant of special vehicle mainly used on industrial premises injured in transport accident
0.004 0.995 0.000
V82 Occupant of streetcar injured in transport accident
0.004 0.995 0.000
V81 Occupant of railway train or railway vehicle injured in transport accident
0.004 0.995 0.000
X40-X49 Accidental poisoning by and exposure to noxious substances
0.004 0.995 0.000
Y40 Systemic antibiotics
0.005 0.995 0.000
V17 Pedal cyclist injured in collision with fixed or stationary object
0.004 0.995 0.000
V47 Car occupant injured in collision with fixed or stationary object
0.004 0.995 0.000
V46 Car occupant injured in collision with other nonmotor vehicle
0.004 0.995 0.000
V45 Car occupant injured in collision with railway train or railway vehicle
0.004 0.995 0.000
V43 Car occupant injured in collision with car, pick-up truck or van
0.004 0.995 0.000
V42 Car occupant injured in collision with two- or three-wheeled motor vehicle
0.004 0.995 0.000
V41 Car occupant injured in collision with pedal cycle
0.004 0.995 0.000
V40 Car occupant injured in collision with pedestrian or animal
0.004 0.995 0.000
Y04 Assault by bodily force
0.004 0.995 0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.004 0.995 0.000
Y44 Agents primarily affecting blood constituents
0.004 0.995 0.000
X10-X19 Contact with heat and hot substances
0.004 0.995 0.000
Y85.0 Sequelae of motor-vehicle accident
0.004 0.995 0.000
Y46.6 Other and unspecified antiepileptics
0.004 0.996 0.000
Y56.9 Topical agent, unspecified
0.004 0.996 0.000
Y56.8 Other topical agents
0.004 0.996 0.000
Y56.7 Dental drugs, topically applied
0.004 0.996 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.004 0.996 0.000
Y56.5 Ophthalmological drugs and preparations
0.004 0.996 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.004 0.996 0.000
Y56.3 Emollients, demulcents and protectants
0.004 0.996 0.000
Y56.2 Local astringents and local detergents
0.004 0.996 0.000
Y56.1 Antipruritics
0.004 0.996 0.000
V49.8 Car occupant [any] injured in other specified transport accidents
0.004 0.996 0.000
V49.5 Passenger injured in collision with other and unspecified motor vehicles in traffic accident
0.004 0.996 0.000
V49.3 Car occupant [any] injured in unspecified nontraffic accident
0.004 0.996 0.000
V49.2 Unspecified car occupant injured in collision with other and unspecified motor vehicles in nontraffic accident
0.004 0.996 0.000
V49.1 Passenger injured in collision with other and unspecified motor vehicles in nontraffic accident
0.004 0.996 0.000
V49.0 Driver injured in collision with other and unspecified motor vehicles in nontraffic accident
0.004 0.996 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.004 0.996 0.000
E14.8 With unspecified complications
0.004 0.996 0.000
E14.7 With multiple complications
0.004 0.996 0.000
E14.6 With other specified complications
0.004 0.996 0.000
E14.5 With peripheral circulatory complications
0.004 0.996 0.000
E14.4 With neurological complications
0.004 0.996 0.000
E14.2 Withrenal complications
0.004 0.996 0.000
E14.1 With ketoacidosis
0.004 0.996 0.000
E14.0 With coma
0.004 0.996 0.000
Y70-Y82 Medical devices associated with adverse incidents in diagnostic and therapeutic use
0.004 0.996 0.000
Y09 Assault by unspecified means
0.004 0.996 0.000
Y08 Assault by other specified means
0.004 0.996 0.000
Y07 Other maltreatment syndromes
0.004 0.996 0.000
Y06 Neglect and abandonment
0.004 0.996 0.000
Y05 Sexual assault by bodily force
0.004 0.996 0.000
Y03 Assault by crashing of motor vehicle
0.004 0.996 0.000
Y02 Assault by pushing or placing victim before moving object
0.004 0.996 0.000
Y01 Assault by pushing from high place
0.004 0.996 0.000
X60-X84 Intentional self-harm
0.004 0.996 0.000
E13 Other specified diabetes mellitus
0.004 0.996 0.000
W87 Exposure to unspecified electric current
0.004 0.996 0.000
X20-X29 Contact with venomous animals and plants
0.004 0.996 0.000
Y89.1 Sequelae of war operations
0.004 0.996 0.000
Y89.0 Sequelae of legal intervention
0.004 0.996 0.000
V27 Motorcycle rider injured in collision with fixed or stationary object
0.004 0.996 0.000
Y57.6 Other diagnostic agents
0.004 0.996 0.000
E12.9 Without complications
0.004 0.996 0.000
E12.8 With unspecified complications
0.004 0.996 0.000
E12.7 With multiple complications
0.004 0.996 0.000
E12.6 With other specified complications
0.004 0.996 0.000
E12.5 With peripheral circulatory complications
0.004 0.996 0.000
E12.4 With neurological complications
0.004 0.996 0.000
E12.3 With ophthalmic complications
0.004 0.996 0.000
E12.2 With renal complications
0.004 0.996 0.000
E12.1 With ketoacidosis
0.004 0.996 0.000
E12.0 With coma
0.004 0.996 0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.004 0.996 0.000
Y49.9 Psychotropic drug, unspecified
0.004 0.996 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.004 0.996 0.000
Y49.7 Psychostimulants with abuse potential
0.004 0.996 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.004 0.996 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.004 0.996 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.004 0.996 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.004 0.996 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.004 0.996 0.000
E11.2 With renal complications
0.004 0.996 0.000
Y54.9 Mineral salts, not elsewhere classified
0.004 0.996 0.000
Y54.7 Agents affecting calcification
0.004 0.996 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.004 0.996 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.004 0.996 0.000
Y54.0 Mineralocorticoids
0.004 0.996 0.000
V11 Pedal cyclist injured in collision with other pedal cycle
0.004 0.996 0.000
X50 Overexertion and strenuous or repetitive movements
0.004 0.996 0.000
I00-I02 Acute rheumatic fever
0.004 0.996 0.000
D25.9 Leiomyoma of uterus, unspecified
0.000 0.996 0.004
Y84 Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
0.004 0.996 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.004 0.996 0.000
Y00.8 Other specified place
0.004 0.996 0.000
Y00.4 Street and highway
0.004 0.996 0.000
Y00.2 School, other institution and public administrative area
0.004 0.996 0.000
Y00.7 Farm
0.004 0.996 0.000
Y00.6 Industrial and construction area
0.004 0.996 0.000
Y00.5 Trade and service area
0.004 0.996 0.000
Y00.3 Sports and athletics area
0.004 0.996 0.000
Y00.1 Residential institution
0.004 0.996 0.000
Y00.0 Home
0.004 0.996 0.000
Y46.8 Antispasticity drugs
0.004 0.996 0.000
Y46.7 Anti-Parkinsonism drugs
0.004 0.996 0.000
Y46.5 Valproic acid
0.004 0.996 0.000
Y46.3 Deoxybarbiturates
0.004 0.996 0.000
Y46.2 Hydantoin derivatives
0.004 0.996 0.000
Y46.1 Oxazolidinediones
0.004 0.996 0.000
Y46.0 Succinimides
0.004 0.996 0.000
Y85.9 Sequelae of other and unspecified transport accidents
0.004 0.996 0.000
Y83-Y84 Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
0.004 0.996 0.000
O04.9 Complete or unspecified, without complication
0.000 0.996 0.004
Y84.8 Other medical procedures
0.004 0.996 0.000
Y54.4 Loop [high-ceiling] diuretics
0.004 0.996 0.000
V04 Pedestrian injured in collision with heavy transport vehicle or bus
0.004 0.996 0.000
Y49.2 Other and unspecified antidepressants
0.004 0.996 0.000
K85.3 Drug-induced acute pancreatitis
0.004 0.996 0.000
K85.0 Idiopathic acute pancreatitis
0.004 0.996 0.000
Y46.4 Iminostilbenes
0.004 0.996 0.000
I12.9 Hypertensive renal disease without renal failure
0.004 0.996 0.000
K85.8 Other acute pancreatitis
0.004 0.996 0.000
N80.0 Endometriosis of uterus
0.004 0.996 0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent
0.004 0.996 0.000
E14.3 With ophthalmic complications
0.004 0.996 0.000
V17.4 Driver injured in traffic accident
0.004 0.996 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.004 0.996 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.004 0.996 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.004 0.996 0.000
Y47.4 Bromine compounds
0.004 0.996 0.000
Y47.3 Paraldehyde
0.004 0.996 0.000
Y47.2 Chloral derivatives
0.004 0.996 0.000
Y47.1 Benzodiazepines
0.004 0.996 0.000
Y47.0 Barbiturates, not elsewhere classified
0.004 0.996 0.000
Y50.9 Central nervous system stimulant, unspecified
0.004 0.996 0.000
Y50.8 Other central nervous system stimulants
0.004 0.996 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.004 0.996 0.000
Y50.1 Opioid receptor antagonists
0.004 0.996 0.000
Y50.0 Analeptics
0.004 0.996 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.004 0.996 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.004 0.996 0.000
Y55.5 Anticommon cold drugs
0.004 0.996 0.000
Y55.4 Expectorants
0.004 0.996 0.000
Y55.3 Antitussives
0.004 0.996 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.004 0.996 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.004 0.996 0.000
Y55.0 Oxytocic drugs
0.004 0.996 0.000
Y58.9 Other and unspecified bacterial vaccines
0.004 0.996 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.004 0.996 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.004 0.996 0.000
Y58.5 Diphtheria vaccine
0.004 0.996 0.000
Y58.4 Tetanus vaccine
0.004 0.996 0.000
Y58.3 Plague vaccine
0.004 0.996 0.000
Y58.2 Cholera vaccine
0.004 0.996 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.004 0.996 0.000
Y58.0 BCG vaccine
0.004 0.996 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.